valproic acid has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Kawagoe, H; Kawagoe, R; Sano, K | 1 |
| Blum, W; Chan, KK; Huynh, L; Klisovic, RB; Liu, S; Liu, Z; Marcucci, G; Neviani, P; Pang, J; Paschka, P; Perrotti, D; Vukosavljevic, T; Yu, J | 1 |
| Cai, Y; Dai, XY; Guan, QC; Guan, Y; Kong, W; Wang, X; Xu, MJ; Zhao, MM; Zhao, Y; Zhu, WG | 1 |
4 other study(ies) available for valproic acid and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspases; Cytochrome c Group; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Leukemia; Tumor Cells, Cultured; Valproic Acid | 2002 |
Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Topics: Acetylation; Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 3; Caspase 9; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Chromatin Assembly and Disassembly; Chromatin Immunoprecipitation; Core Binding Factor Alpha 2 Subunit; Cysteine Proteinase Inhibitors; DNA; Gene Expression Regulation, Leukemic; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Interleukin-3; Leukemia, Myeloid, Acute; Oncogene Proteins, Fusion; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Protein Binding; Repressor Proteins; RNA Polymerase II; RUNX1 Translocation Partner 1 Protein; Valproic Acid | 2007 |
Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release.
Topics: Adenine; Alkaline Phosphatase; Amino Acid Chloromethyl Ketones; Animals; Antioxidants; Autophagy; Autophagy-Related Protein 5; Caspase Inhibitors; Cattle; Cells, Cultured; Disease Models, Animal; Kidney Failure, Chronic; Metalloporphyrins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphates; Proteins; Rats; RNA Interference; Secretory Vesicles; Sodium-Phosphate Cotransporter Proteins, Type III; Superoxide Dismutase; Time Factors; Transfection; Valproic Acid; Vascular Calcification | 2013 |